Evaluation of host cellular responses to Epstein–Barr virus (EBV) in adult lung transplant patients with EBV‐associated diseases
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Medical Virology"
DOI: 10.1002/jmv.28724
Abstract: Epstein–Barr virus (EBV) reactivation is commonly observed in lung transplant recipients (LTRs). However, cellular immune responses to EBV in adult LTRs have not been well described. We aimed to study CD4/CD8 ratio, EBV‐specific T cells… read more here.
Keywords: dnaemia; ebv; ebv dnaemia; ebv adult ... See more keywords
Longitudinal monitoring of Torque Teno virus DNAemia in kidney transplant recipients correlates with long‐term complications of inadequate immunosuppression
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Medical Virology"
DOI: 10.1002/jmv.29806
Abstract: Optimization of individual immunosuppression, which reduces the risks of both graft loss and patients' death, is considered the best approach to improve long‐term outcomes of renal transplantation. Torque Teno Virus (TTV) DNAemia has emerged as… read more here.
Keywords: long term; inadequate immunosuppression; immunosuppression; ttv dnaemia ... See more keywords
Refractory cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation: when should genotypic drug resistance testing be requested?
Sign Up to like & getrecommendations! Published in 2018 at "Bone Marrow Transplantation"
DOI: 10.1038/s41409-018-0191-8
Abstract: Persisting cytomegalovirus (CMV) DNAemia in spite of appropriate antiviral therapy is a risk factor for CMV disease and non-relapse mortality in allogeneic hematopoietic stem cell transplant recipients (allo-HSCT) [1], and may be due to a… read more here.
Keywords: cmv; resistance; dnaemia; cmv dna ... See more keywords
Transient Parvovirus B19 DNAemia After Kidney Transplantation: A 2-Sided Story
Sign Up to like & getrecommendations! Published in 2023 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofad079
Abstract: Abstract Parvovirus B19 (B19V) DNAemia appears to be a relatively common finding after kidney transplantation. However, not all DNAemia signifies active infection with replicating virus. This study screened 134 patients posttransplantation for B19V DNAemia and… read more here.
Keywords: parvovirus b19; kidney transplantation; kidney; dnaemia ... See more keywords
P-2362. Risk Factors for Persistent and Recurrent CMV DNAemia in a Real-World Cohort of SOT and HSCT Patients Receiving Maribavir
Sign Up to like & getrecommendations! Published in 2025 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofae631.2513
Abstract: Abstract Background Refractory/resistant (R/R) CMV infection, defined by persistent symptoms or DNAemia after at least two weeks of antiviral therapy, is associated with high rates of rejection and mortality in transplant patients. Maribavir (MBV) is… read more here.
Keywords: sot; cmv; risk factors; dnaemia ... See more keywords
Incidence of Cytomegalovirus DNAemia in Pediatric Kidney Transplant Recipients After Cessation of Antiviral Prophylaxis
Sign Up to like & getrecommendations! Published in 2018 at "Transplantation"
DOI: 10.1097/tp.0000000000002115
Abstract: Background Late cytomegalovirus (CMV) infection can occur after cessation of viral prophylaxis in kidney transplant recipients, yet, timing of infection is unclear and longer duration of prophylaxis may be warranted. Methods We conducted a retrospective… read more here.
Keywords: incidence; cmv; antiviral prophylaxis; transplant ... See more keywords
Epidemiology and long‐term outcomes of cytomegalovirus DNAemia and disease in pediatric solid organ transplant recipients
Sign Up to like & getrecommendations! Published in 2021 at "American Journal of Transplantation"
DOI: 10.1111/ajt.16822
Abstract: Despite prevention strategies, cytomegalovirus (CMV) remains a common infection in pediatric solid organ transplant recipients (SOTR). We sought to determine the frequency, associations with, and long‐term outcomes of CMV DNAemia in pediatric SOTR. We performed… read more here.
Keywords: epidemiology; pediatric solid; dnaemia; transplant recipients ... See more keywords
Features of cytomegalovirus DNAemia and virus‐specific T‐cell responses in allogeneic hematopoietic stem‐cell transplant recipients during prophylaxis with letermovir
Sign Up to like & getrecommendations! Published in 2023 at "Transplant Infectious Disease"
DOI: 10.1111/tid.14021
Abstract: There is scarce information on the natural kinetics of cytomegalovirus (CMV) DNAemia and dynamics of CMV‐specific T‐cell reconstitution in allogeneic hematopoietic transplant recipients (allo‐HSCT) undergoing letermovir (LMV) prophylaxis. read more here.
Keywords: cell; allogeneic hematopoietic; specific cell; dnaemia ... See more keywords
Early clearance of BK polyomavirus‐DNAemia among kidney transplant recipients may lead to better graft survival
Sign Up to like & getrecommendations! Published in 2024 at "Transplant Infectious Disease"
DOI: 10.1111/tid.14371
Abstract: BK polyomavirus (BKPyV)‐DNAemia is a common complication in kidney transplant recipients (KTRs). The significance of achieving viral clearance at different time intervals is not well understood. read more here.
Keywords: transplant recipients; polyomavirus; transplant; kidney transplant ... See more keywords
A Comprehensive Statistical Framework for Determination of Commutability, Accuracy, and Agreement in Clinical DNAemia Assays
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.00963-18
Abstract: Despite advances in the standardization of quantitative DNAemia tests and efforts to better understand and characterize the performance of reference materials in different assays, it remains unclear how the commutability performance of reference materials is… read more here.
Keywords: agreement; framework; commutability; accuracy agreement ... See more keywords
Optimizing letermovir timing: Day +5 to +8 post haplo-HSCT minimizes EBV dnaemia without compromising CMV prophylaxis
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-2500
Abstract: Background The era of Letermovir (LTV) has reshaped CMV prophylaxis and treatment following allogeneic HSCT, with its efficacy in reducing CMV infection well established. However, emerging evidence suggests an association between LTV exposure and increased… read more here.
Keywords: cohort cohort; cohort; ebv dnaemia; cmv ... See more keywords